1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Mental Health Analysis & Statistics in Australia, July 2019

Mental Health Analysis & Statistics in Australia, July 2019

Customer Support

Talk to Veronica

+1 718 514 2762

All regions

1-12 of 12 reports

Antisense Therapeutics Ltd (ANP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Antisense Therapeutics Ltd (ANP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2018

SummaryAntisense Therapeutics Ltd (Antisense Therapeutics) is clinical staged biopharmaceutical company which focuses on the discovery, development and commercialization of second generation antisense ...

  • Industries : Therapy, Medical Biotechnology, Pharmaceutical, Biopharmaceutical, Biopharmaceutical
  • Countries : Australia
Australia Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and Others

Australia Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and Others

  • $ 5995
  • Industry report
  • November 2018

Australia Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and OthersSummaryGlobalData’s new report, Australia Neurology ...

  • Industries : Health Services, Healthcare, Mental Health, Patient Monitoring, Medical Device, Pathology
  • Countries : Australia, Australasia, Oceania
Psychiatric Hospitals in Australia - Industry Market Research Report

Psychiatric Hospitals in Australia - Industry Market Research Report

  • $ 905
  • Industry report
  • October 2018

Social welfare: Emphasis on community-based preventative treatments has constrained growthAbstractPsychiatric Hospitals in AustraliaThe industry consists of psychiatric hospitals that primarily provide ...

  • Industries : Health Services, Healthcare, Mental Health
  • Countries : Australia
Corticosteroid 11 Beta Dehydrogenase Isozyme 1 (11 Beta Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or HSD11B1 or EC 1.1.1.146) - Pipeline Review, H2 2018

Corticosteroid 11 Beta Dehydrogenase Isozyme 1 (11 Beta Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or HSD11B1 or EC 1.1.1.146) - Pipeline Review, H2 2018

  • $ 3500
  • Company report
  • October 2018

Corticosteroid 11 Beta Dehydrogenase Isozyme 1 (11 Beta Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or HSD11B1 or EC 1.1.1.146) - Pipeline Review, H2 2018 ...

  • Industries : Therapy, Pathology, Mental Health
  • Countries : Australia
Cogstate Ltd (CGS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cogstate Ltd (CGS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummaryCogstate Ltd (Cogstate) is a cognitive science company that provides technology solutions.The company offers scientific consulting, precision recruitment and computerized assessment, among others.It ...

  • Industries : Healthcare, Pharmaceutical, Pathology
  • Countries : Canada, Australia, United States, World
University of New South Wales - Pharmaceuticals & Healthcare - Deals and Alliances Profile

University of New South Wales - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2018

SummaryUniversity of New South Wales (UNSW Australia) is an academic university that offer research and education services.The university’s educational services include fine arts education, design, media ...

  • Industries : Pathology
  • Countries : Australia
The University of New South Wales - Pharmaceuticals & Healthcare - Deals and Alliances Profile

The University of New South Wales - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • June 2018

SummaryThe University of New South Wales (UNSW Australia) is an academic university that offer research and education services.The university’s educational services include fine arts education, design, ...

  • Industries : Pathology
  • Countries : Australia
Corticosteroid 11 Beta Dehydrogenase Isozyme 1 (11 Beta Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or HSD11B1 or EC 1.1.1.146) - Pipeline Review, H1 2018

Corticosteroid 11 Beta Dehydrogenase Isozyme 1 (11 Beta Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or HSD11B1 or EC 1.1.1.146) - Pipeline Review, H1 2018

  • $ 3500
  • Company report
  • April 2018

Corticosteroid 11 Beta Dehydrogenase Isozyme 1 (11 Beta Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or HSD11B1 or EC 1.1.1.146) - Pipeline Review, H1 2018 ...

  • Industries : Pathology, Therapy, Pharmaceutical, Mental Health
  • Countries : World, United Kingdom, United States, Australia, Australasia
Magnetic Resonance Imaging Systems - Medical Devices Pipeline Assessment, 2017

Magnetic Resonance Imaging Systems - Medical Devices Pipeline Assessment, 2017

  • $ 4000
  • Industry report
  • September 2017

Magnetic Resonance Imaging Systems - Medical Devices Pipeline Assessment, 2017SummaryGlobalData’s Medical Devices sector report, “Magnetic Resonance Imaging Systems - Medical Devices Pipeline Assessment, ...

  • Industries : Diagnostic Imaging, Medical Device, Drug Development
  • Countries : United States, Australia, North America
Neurosurgical Products - Medical Devices Pipeline Assessment, 2017

Neurosurgical Products - Medical Devices Pipeline Assessment, 2017

  • $ 4000
  • Industry report
  • August 2017

Neurosurgical Products - Medical Devices Pipeline Assessment, 2017SummaryGlobalData’s Medical Devices sector report, “Neurosurgical Products - Medical Devices Pipeline Assessment, 2017" provides an ...

  • Industries : Drug Development, Health Services, Pharmaceutical, Healthcare
  • Countries : Australia, United States
Epilepsy Therapeutic Market in APAC 2017-2021

Epilepsy Therapeutic Market in APAC 2017-2021

  • $ 2500
  • Industry report
  • June 2017

About Epilepsy Therapeutic Epilepsy is a neurological condition that affects the nervous system. It is characterized by the occurrence of two or more unprovoked seizures. A seizure is defined as the disruption ...

  • Industries : Mental Health, Therapy, Pathology, Pharmaceutical
  • Countries : Japan, World, East Asia, China, Australia, India
Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H2 2016

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • July 2016

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H2 2016SummaryGlobal Markets Direct’s, ‘Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H2 2016’, provides an ...

  • Industries : Pathology, Mental Health, Therapy, Pharmaceutical
  • Countries : United States, Australia, World



Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on